Polen Capital's position in Thermo Fisher Scientific is currently worth $1.01 Billion. That's 2.88% of their equity portfolio (18th largest holding). The first Thermo Fisher Scientific trade was made in Q4 2022. Since then Polen Capital bought shares two more times and sold shares on six occasions. The investor's estimated purchase price is $1.33 Billion, resulting in a loss of 24%.
Polen Capital, an investment management company, released its “Polen Focus Growth Strategy” first quarter 2024 investor letter. A copy of the same can be dow...
On CNBC’s " Halftime Report Final Trades ," Stephen Weiss of Short Hills Capital Partners picked GXO Logistics, Inc. (NYSE: GXO ), saying they do well each q...
… funds and other institutional investors have also recently added … last quarter. Summit Global Investments raised its stake in shares … third quarter. Summ...
… Commission (SEC). The institutional investor purchased 15,900 shares … 164,000. Other institutional investors and hedge funds have also … .71. Want More Gr...